시장보고서
상품코드
1150084

세계의 줄기세포 치료 시장 점유율, 규모, 동향, 산업 분석 리포트 : 유형별, 세포 소스별, 치료 용도별, 지역별, 부문 예측(2022-2030년)

Stem Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Type (Allogeneic, Autologous); By Cell Source; By Therapeutic Application; By Region; Segment Forecast, 2022 - 2030

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 117 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 줄기세포 치료 시장 규모는 2030년까지 9억 8만 달러에 달할 것으로 예측되고 있습니다.

세계의 줄기세포 치료 시장에 대해 조사분석했으며, 시장 역학, 부문 분석, 지역 분석, 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

  • 리포트 설명
    • 조사 목적
    • 시장 범위
    • 전제조건
  • 이해관계자

제2장 주요 요약

  • 시장 하이라이트

제3장 조사 방법

  • 개요
    • 데이터 마이닝
  • 데이터 소스
    • 1차 소스
    • 2차 소스

제4장 세계의 줄기세포 치료 시장 인사이트

  • 줄기세포 치료 : 업계의 스냅숏
  • 줄기세포 치료 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter's Five Forces 분석
    • 공급 기업의 교섭력(중)
    • 신규 참여업체의 위협(저)
    • 구매자의 교섭력(중)
    • 대체품의 위협(중)
    • 기존 기업간 경쟁력(고)
  • PESTEL 분석
  • 줄기세포 치료 시장 업계 동향
  • 밸류체인 분석
  • COVID-19 영향 분석

제5장 세계의 줄기세포 치료 시장 : 유형별

  • 주요 조사 결과
  • 서론
    • 유형별 : 2018-2030년
  • 동종
    • 동종별, 지역별 : 2018-2030년
  • 자기
    • 자기별, 지역별 : 2018-2030년

제6장 세계의 줄기세포 치료 시장 : 세포 소스별

  • 주요 조사 결과
  • 서론
    • 세포 소스별 : 2018-2030년
  • 지방조직 유래 MSC(중간엽 줄기세포)
    • 지방조직 유래 MSC(중간엽 줄기세포)별, 지역별 : 2018-2030년
  • 골수 유래 MSC
    • 골수 유래 MSC별, 지역별 : 2018-2030년
  • 태반/제대 유래 MSC
    • 태반/제대 유래 MSC별, 지역별 : 2018-2030년
  • 기타 세포 소스
    • 기타 세포 소스별, 지역별 : 2018-2030년

제7장 세계의 줄기세포 치료 시장 : 치료 용도별

  • 주요 조사 결과
  • 서론
    • 치료 용도별 : 2018-2030년
  • 근골격계 질환
    • 근골격계 질환별, 지역별 : 2018-2030년
  • 상처·부상
    • 상처·부상별, 지역별 : 2018-2030년
  • 심혈관질환
    • 심혈관질환별, 지역별 : 2018-2030년
  • 수술
    • 수술별, 지역별 : 2018-2030년
  • 염증성·자가면역질환
    • 염증성·자가면역질환별, 지역별 : 2018-2030년
  • 신경질환
    • 신경질환별, 지역별 : 2018-2030년
  • 기타 치료 용도
    • 기타 치료 용도별, 지역별 : 2018-2030년

제8장 세계의 줄기세포 치료 시장 : 지역별

  • 주요 조사 결과
  • 서론
    • 줄기세포 치료 시장 평가 - 지역별 : 2018-2030년
  • 북미
    • 유형별 : 2018-2030년
    • 치료 용도별 : 2018-2030년
    • 세포 소스별 : 2018-2030년
    • 미국
    • 캐나다
  • 유럽
    • 유형별 : 2018-2030년
    • 치료 용도별 : 2018-2030년
    • 세포 소스별 : 2018-2030년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
  • 아시아태평양
    • 유형별 : 2018-2030년
    • 치료 용도별 : 2018-2030년
    • 세포 소스별 : 2018-2030년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
  • 중동·아프리카
    • 유형별 : 2018-2030년
    • 치료 용도별 : 2018-2030년
    • 세포 소스별 : 2018-2030년
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
  • 라틴아메리카
    • 유형별 : 2018-2030년
    • 치료 용도별 : 2018-2030년
    • 세포 소스별 : 2018-2030년
    • 멕시코
    • 브라질
    • 아르헨티나

제9장 경쟁 구도

  • 사업 확장과 인수 분석
    • 사업 확장
    • 인수
  • 제휴/협업/협정/전시회

제10장 기업 개요

  • Advanced Cell Technology Inc.
  • Angel Biotechnology
  • Bioheart Inc.
  • Brainstorm Cell Therapeutics
  • Caladrius Biosciences
  • Celgene Corporation
  • Cellartis AB
  • CellGenix GmbH
  • Cellular Engineering Technologies Inc.
  • Gamida Cell
  • Genea Biocells
  • Kite Pharma
  • Lonza
  • Osiris Therapeutics
  • PromoCell GmbH
  • STEMCELL Technologies Inc.
  • Tigenix
  • Waisman Biomanufacturing
KSA 22.11.18

The global stem cell therapy market size is expected to reach USD 900.08 million by 2030 according to a new study by Polaris Market Research. The report "Stem Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Type (Allogeneic, Autologous); By Cell Source; By Therapeutic Application; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing prevalence of chronic disorders, increasing GMP certification approvals for cell therapy production with higher spending in medical research, and the growing number of clinical studies related to stem cell therapies are driving the market.

Increasing collaboration activities by market players are expected to drive the growth of the global market. For instance, in May 2018, Procella Therapeutics and Smartwise collaborated with AstraZeneca Pharmaceuticals to develop stem cell therapies in cardiovascular diseases using Procella Therapeutics' stem cell technology.

COVID-19 has opened up new avenues for stem cell therapy. For COVID-19 patients, several stem cell-based regenerative medicine therapy clinical trials were conducted. Clinical trials are recognized as indispensable components of the pharmaceutical industry and the best hope for patients suffering from diseases.

Stem Cell Therapy Market Report Highlights

The allogenic type accounted for a significant market revenue in 2021 due to the growing demand for omidubicel used to treat cancer patients.

The adipose tissue-derived stem cell will acquire largest market revenue in 2021 as it poses properties such as self-sustainability and multipotential differentiation.

Musculoskeletal disorders segment is anticipated to hold a significant share due to rising R&D expenditures in stem cell therapies to cure these disorders.

North America accounted for the largest market revenue due to advanced healthcare infrastructure and rising R&D units in this region.

The global market is highly competitive owing to large industry players such as Advanced Cell Technology Inc., Angel Biotechnology, Bioheart Inc., Brainstorm Cell Therapeutics, Caladrius Biosciences, Celgene Corporation, Cellartis AB, CellGenix GmbH, Cellular Engineering Technologies Inc., Gamida Cell, Genea Biocells, Kite Pharma, Lonza, Osiris Therapeutics, PromoCell GmbH, STEMCELL Technologies Inc., Tigenix, and Waisman Biomanufacturing.

Polaris Market Research has segmented the stem cell therapy market report based on type, cell source, therapeutic application, and regions:

Stem Cell Therapy, Type Outlook (Revenue - USD Million, 2018 - 2030)

Allogeneic

Autologous

Stem Cell Therapy, Cell Source Outlook (Revenue - USD Million, 2018 - 2030)

Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)

Bone Marrow-derived MSCs

Placental/Umbilical Cord-derived MSCs

Other Cell Sources

Stem Cell Therapy, Therapeutic Application Outlook (Revenue - USD Million, 2018 - 2030)

Musculoskeletal Disorders

Wounds & Injuries

Cardiovascular Diseases

Surgeries

Inflammatory & Autoimmune Diseases

Neurological Diseases

Other Therapeutic Applications

Stem Cell Therapy, Regional Outlook (Revenue - USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Stem Cell Therapy Market Insights

  • 4.1. Stem Cell Therapy - Industry Snapshot
  • 4.2. Stem Cell Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Ongoing Developments In Regenerative Medicine
      • 4.2.1.2. Rising Funds For Accelerating Stem Cell Research
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Ethical Concern Related To Stem Cell Research
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Stem Cell Therapy Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Stem Cell Therapy Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
  • 5.3. Allogeneic
    • 5.3.1. Global Stem Cell Therapy Market, by Kinetic, by Allogeneic, 2018 - 2030 (USD Million)
  • 5.4. Autologous
    • 5.4.1. Global Stem Cell Therapy Market, by Autologous, by Region, 2018 - 2030 (USD Million)

6. Global Stem Cell Therapy Market, by Cell Source

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 6.3. Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
    • 6.3.1. Global Stem Cell Therapy Market, by Adipose Tissue-derived MSCs (Mesenchymal Stem Cells), by Region, 2018 - 2030 (USD Million)
  • 6.4. Bone Marrow-derived MSCs
    • 6.4.1. Global Stem Cell Therapy Market, by Bone Marrow-derived MSCs, by Region, 2018 - 2030 (USD Million)
  • 6.5. Placental/Umbilical Cord-derived MSCs
    • 6.5.1. Global Stem Cell Therapy Market, by Placental/Umbilical Cord-derived MSCs, by Region, 2018 - 2030 (USD Million)
  • 6.6. Other Cell Sources
    • 6.6.1. Global Stem Cell Therapy Market, by Other Cell Sources, by Region, 2018 - 2030 (USD Million)

7. Global Stem Cell Therapy Market, by Therapeutic Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 7.3. Musculoskeletal Disorders
    • 7.3.1. Global Stem Cell Therapy Market, by Musculoskeletal Disorders, by Region, 2018 - 2030 (USD Million)
  • 7.4. Wounds & Injuries
    • 7.4.1. Global Stem Cell Therapy Market, by Wounds & Injuries, by Region, 2018 - 2030 (USD Million)
  • 7.5. Cardiovascular Diseases
    • 7.5.1. Global Stem Cell Therapy Market, by Cardiovascular Diseases, by Region, 2018 - 2030 (USD Million)
  • 7.6. Surgeries
    • 7.6.1. Global Stem Cell Therapy Market, by Surgeries, by Region, 2018 - 2030 (USD Million)
  • 7.7. Inflammatory & Autoimmune Diseases
    • 7.7.1. Global Stem Cell Therapy Market, by Inflammatory & Autoimmune Diseases, by Region, 2018 - 2030 (USD Million)
  • 7.8. Neurological Diseases
    • 7.8.1. Global Stem Cell Therapy Market, by Neurological Diseases, by Region, 2018 - 2030 (USD Million)
  • 7.9. Other Therapeutic Applications
    • 7.9.1. Global Stem Cell Therapy Market, by Other Therapeutic Applications, by Region, 2018 - 2030 (USD Million)

8. Global Stem Cell Therapy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Stem Cell Therapy Market Assessment, By Geography, 2018 - 2030 (USD Million)
  • 8.3. Stem Cell Therapy Market - North America
    • 8.3.1. North America: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.3.2. North America: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.3.3. North America: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.3.4. Stem Cell Therapy Market - U.S.
      • 8.3.4.1. U.S.: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.3.4.2. U.S.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.3.4.3. U.S.: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.3.5. Stem Cell Therapy Market - Canada
      • 8.3.5.1. Canada: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.3.5.2. Canada.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.3.5.3. Canada: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.4. Stem Cell Therapy Market - Europe
    • 8.4.1. Europe: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.4.2. Europe.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.4.3. Europe: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.4.4. Stem Cell Therapy Market - UK
      • 8.4.4.1. UK: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.4.4.2. UK.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.4.4.3. UK: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.4.5. Stem Cell Therapy Market - France
      • 8.4.5.1. France: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.4.5.2. France.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.4.5.3. France: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.4.6. Stem Cell Therapy Market - Germany
      • 8.4.6.1. Germany: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.4.6.2. Germany.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.4.6.3. Germany: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.4.7. Stem Cell Therapy Market - Italy
      • 8.4.7.1. Italy: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.4.7.2. Italy.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.4.7.3. Italy: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.4.8. Stem Cell Therapy Market - Spain
      • 8.4.8.1. Spain: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.4.8.2. Spain.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.4.8.3. Spain: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.4.9. Stem Cell Therapy Market - Netherlands
      • 8.4.9.1. Netherlands: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.4.9.2. Netherlands.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.4.9.3. Netherlands: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.4.10. Stem Cell Therapy Market - Russia
      • 8.4.10.1. Russia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.4.10.2. Russia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.4.10.3. Russia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.5. Stem Cell Therapy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.5.2. Asia Pacific.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.5.3. Asia Pacific: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.5.4. Stem Cell Therapy Market - China
      • 8.5.4.1. China: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.5.4.2. China.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.5.4.3. China: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.5.5. Stem Cell Therapy Market - India
      • 8.5.5.1. India: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.5.5.2. India.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.5.5.3. India: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.5.6. Stem Cell Therapy Market - Malaysia
      • 8.5.6.1. Malaysia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.5.6.2. Malaysia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.5.6.3. Malaysia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.5.7. Stem Cell Therapy Market - Japan
      • 8.5.7.1. Japan: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.5.7.2. Japan.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.5.7.3. Japan: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.5.8. Stem Cell Therapy Market - Indonesia
      • 8.5.8.1. Indonesia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.5.8.2. Indonesia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.5.8.3. Indonesia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.5.9. Stem Cell Therapy Market - South Korea
      • 8.5.9.1. South Korea: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.5.9.2. South Korea.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.5.9.3. South Korea: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.6. Stem Cell Therapy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.6.2. Middle East & Africa.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.6.3. Middle East & Africa: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.6.4. Stem Cell Therapy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.6.4.3. Saudi Arabia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.6.5. Stem Cell Therapy Market - UAE
      • 8.6.5.1. UAE: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.6.5.2. UAE.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.6.5.3. UAE: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.6.6. Stem Cell Therapy Market - Israel
      • 8.6.6.1. Israel: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.6.6.2. Israel.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.6.6.3. Israel: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.6.7. Stem Cell Therapy Market - South Africa
      • 8.6.7.1. South Africa: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.6.7.2. South Africa.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.6.7.3. South Africa: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.7. Stem Cell Therapy Market - Latin America
    • 8.7.1. Latin America: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.7.2. Latin America.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.7.3. Latin America: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.7.4. Stem Cell Therapy Market - Mexico
      • 8.7.4.1. Mexico: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.7.4.2. Mexico.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.7.4.3. Mexico: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.7.5. Stem Cell Therapy Market - Brazil
      • 8.7.5.1. Brazil: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.7.5.2. Brazil.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.7.5.3. Brazil: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
    • 8.7.6. Stem Cell Therapy Market - Argentina
      • 8.7.6.1. Argentina: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
      • 8.7.6.2. Argentina.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
      • 8.7.6.3. Argentina: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Advanced Cell Technology Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Angel Biotechnology
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bioheart Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Brainstorm Cell Therapeutics
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Caladrius Biosciences
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Celgene Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Cellartis AB
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. CellGenix GmbH
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Cellular Engineering Technologies Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Gamida Cell
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Genea Biocells
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Kite Pharma
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Lonza
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Osiris Therapeutics
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. PromoCell GmbH
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. STEMCELL Technologies Inc.
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. Tigenix
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development
  • 10.18. Waisman Biomanufacturing
    • 10.18.1. Company Overview
    • 10.18.2. Financial Performance
    • 10.18.3. Product Benchmarking
    • 10.18.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제